Category III CPT Codes - UHCprovider.com
Speech audiometry threshold, automated; 0211T : Speech audiometry threshold, automated; with speech recognition . 0212T : Comprehensive audiometry threshold evaluation and speech recognition (0209T, 0211T combined), automated . 0213T : Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves
Tags:
Code, Category, Diagnostics, Thresholds, Cpt category iii codes
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Coverage Summary - UHCprovider.com Home
www.uhcprovider.comThe benefit information in this Coverage Summary is based on existing national coverage ... Also see the Medicare Prescription Drug Benefit Manual,Chapter 6, ...
Manual, Prescription, Drug, Benefits, Summary, Coverage, Prescription drug benefit manual, Coverage summary
UnitedHealthcare Group Medicare Advantage …
www.uhcprovider.comUnitedHealthcare® Group Medicare Advantage (PPO) Plan Network Care Provider Quick Reference Guide Insurance coverage provided by or through UnitedHealthcare Insurance Company or its affiliates.
Network, Reference, Medicare, Care, Group, Plan, Provider, Quick, Advantage, Unitedhealthcare, Unitedhealthcare group medicare advantage, 174 group medicare advantage, Plan network care provider quick reference
Shoulder Replacement Surgery (Arthroplasty)
www.uhcprovider.comShoulder Replacement Surgery (Arthroplasty) ... FDA-approved reverse shoulder replacement surgery devices are generally approved for gross rotator cuff deficiency. The patient's joint must be anatomically and structurally suited to receive the selected implant(s), and a functional
Reserve, Replacement, Shoulder, Arthroplasty, Surgery, Reverse shoulder replacement, Shoulder replacement surgery
NEUROMUSCULAR ELECTRICAL STIMULATION …
www.uhcprovider.comNeuromuscular Electrical Stimulation (NMES) (NCD 160.12) Page 2 of 3 UnitedHealthcare Medicare Advantage Policy Guideline Approved 08/09/2017
Electrical, Stimulation, Neuromuscular, Neuromuscular electrical stimulation, Mens
APREPITANT FOR CHEMOTHERAPY-INDUCED …
www.uhcprovider.comChemotherapy-induced nausea and vomiting (CINV) can range from mild to severe, with the most severe cases resulting in dehydration, malnutrition, metabolic imbalances, and potential withdrawal from future chemotherapy
Induced, Chemotherapy, Aprepitant, Nausea, Chemotherapy induced nausea and, Aprepitant for chemotherapy induced
Clinical Performance Guideline Medical Fertility Solutions ...
www.uhcprovider.comClinical Performance Guideline Fertility Solutions Infertility Medical Necessity Guideline Purpose: To provide an understanding of infertility treatment, issues surrounding infertility surgery, and issues surrounding multiple embryo transfers among individuals faced with the potential loss of fertility.
EXTRACORPOREAL SHOCK WAVE TREATMENT (ESWT)
www.uhcprovider.comExtracorporeal Shock Wave Treatment (ESWT) Page 1 of 4 ... Extracorporeal shock wave therapy (ESWT), using either a high- or low-dose protocol or a radial wave, is considered not medically necessary for all indications, including but not limited to the treatment of:
Treatment, Shocks, West, Therapy, Waves, Extracorporeal, Extracorporeal shock wave therapy, Extracorporeal shock wave treatment
Pervasive Developmental Disorder and Autism Spectrum …
www.uhcprovider.comPervasive Developmental Disorder and Autism Spectrum Disorder: Benefit Interpretation Policy (Effective 01/01/2018) 3 Proprietary Information of UnitedHealthcare.
Spectrum, Developmental, Disorders, Autism, Pervasive, Pervasive developmental disorder and autism spectrum
Pervasive Developmental Disorder and Autism Spectrum …
www.uhcprovider.compervasive developmental disorders include autism, Rett's disorder, childhood disintegrative disorder, Asperger's disorder, and unspecified pervasive developmental disorder. E. …
Spectrum, Developmental, Disorders, Autism, Pervasive, Pervasive developmental disorder and autism spectrum
Approval Date: October 10, 2018 - UHCprovider.com Home
www.uhcprovider.comRetinal Prosthesis Page 1 of 3 UnitedHealthcare Medicare Advantage Policy Guideline Approved 10/10/2018 Proprietary Information of UnitedHealthcare.
Related documents
i-Ready® Diagnostic Threshold Levels 2020-2021 - Nebraska
cdn.education.ne.govDisclaimer: Threshold levels are determined by the assessment provider. For more information about the assessment and/or threshold levels, please contact the assessment provider directly. i-Ready® Diagnostic Threshold Levels . 2020-2021 . In the table below, the number ranges in the unshaded rows of columns A–C are i‐Ready Diagnostic scale ...
Levels, 2012, 2200, Diagnostics, Thresholds, 2020 2021, Diagnostic threshold levels 2020 2021, Threshold levels, Diagnostic threshold levels
2021 Medicare Physician Fee Schedule - Final Rule
advocatercm.comE&M Code 2020 RVUs 2021 RVUs New Patients 99201 0.48 Removed 99202 0.93 0.93 99203 1.42 1.60 99204 2.43 2.60 ... Threshold Exceptional Performance Threshold Payment Adjustments ... •Can be submitted at individual, group, or APM Entity levels
Levels, 2012, 2200, Thresholds
Molecular Diagnostic Infectious Disease Testing
www.uhcprovider.comMolecular Diagnostic Infectious Disease Testing Page 1 of 23 ... and/or failure to reach the reasonable and necessary threshold for coverage (based on quality of clinical evidence and strength of recommendation). Furthermore, payment of claims in the past (based on stacking codes) or in the ... (Effective 01/01/2020) 0202U ; Infectious disease ...
Testing, Disease, Infectious, 2200, Molecular, Diagnostics, Thresholds, Molecular diagnostic infectious disease testing
Ct Values: What They Are and How They Can be Used - APHL
www.aphl.orgDiagnostic laboratories should not include Ct values on laboratory reports because it could ... threshold” value. A Ct value is defined as the number of amplification cycles required to reach a fixed background level ... On December 10, 2020, FDA posted an update to the frequently asked questions. 3. stating that it is allowable for
NATIONAL POLICY FOR RARE DISEASES, 2021
main.mohfw.gov.indefinitions included a prevalence threshold. The average prevalence thresholds used to define rare diseases ranges among different jurisdictions from 1 to 6 cases/10,000 people, with WHO recommending a prevalence less than 10/10,000 population for defining rare diseases.
Commission on aCCreditation implementing regulations
www.apa.orgif a program meets the IR D.4-7 threshold as determined by the Annual Report Online (“ARO”) in a given year, it means that the program does not need to provide additional reports on that specific threshold in that year. It is important to understand that meeting these thresholds simply means that the program's reported
Helicobacter pylori
www.worldgastroenterology.org4 –12]on . As the field is changing rapidly, there is a need for periodic updating and revision of these position papers. In addition, it is difficult very for guidelines to …